je.st
news
U.S. FDA approves Amgen leukemia drug ahead of schedule
2014-12-04 00:02:10| Biotech - Topix.net
U.S. health regulators on Wednesday approved an Amgen Inc drug that helps the immune system fight a rare type of leukemia, more than five months ahead of the expected decision date. The drug, blinatumomab, which will be sold under the brand name Blincyto, was approved to treat a form of acute lymphoblastic leukemia for which there are currently virtually no treatment options.
Tags: drug
schedule
ahead
fda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||